Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8901
Trevi Therapeutics
TRVI
$2.64B
| $110K | ﹤0.01% |
32,929
-33,439
| -50% | -$99.4K |
|
|
HEPS
8902
D-Market Electronic Services & Trading
HEPS
$990M
| $110K | ﹤0.01% |
48,583
+29,046
| +149% | +$81K |
|
|
MAXN
8903
DELISTED
Maxeon Solar Technologies
MAXN
| $110K | ﹤0.01% |
11,341
-1,256
| -10% | -$20.1K |
|
8904
PUT
NextNav
NN
$2.23B
| $109K | ﹤0.01% |
+14,600
| New | +$113K |
|
8905
Lineage Cell Therapeutics
LCTX
$278M
| $109K | ﹤0.01% |
119,901
-123,054
| -51% | -$114K |
|
|
LLAP
8906
DELISTED
Terran Orbital Corporation
LLAP
| $109K | ﹤0.01% |
432,099
+248,556
| +135% | +$126K |
|
8907
Bakkt Inc
BKKT
$337M
| $108K | ﹤0.01% |
11,330
-41,211
| -78% | -$610K |
|
|
AMPS
8908
DELISTED
Altus Power
AMPS
| $108K | ﹤0.01% |
33,954
-59,500
| -64% | -$212K |
|
8909
CALL
AMC Global Media
AMCX
$489M
| $108K | ﹤0.01% |
+12,400
| New | +$120K |
|
8910
Adicet Bio
ACET
$74.7M
| $108K | ﹤0.01% |
4,673
-8,267
| -64% | -$185K |
|
|
NXDT
8911
NexPoint Diversified Real Estate Trust
NXDT
$238M
| $108K | ﹤0.01% |
17,209
-13,459
| -44% | -$79.9K |
|
8912
Nautilus Biotechnolgy
NAUT
$115M
| $107K | ﹤0.01% |
37,682
-25,020
| -40% | -$64.8K |
|
|
FOCL
8913
PUT
EDAP TMS S.A.
FOCL
$233M
| $107K | ﹤0.01% |
42,000
| – | – |
|
|
SCPH
8914
DELISTED
scPharmaceuticals
SCPH
| $107K | ﹤0.01% |
23,485
-20,206
| -46% | -$97.7K |
|
|
GLDD
8915
CALL
DELISTED
Great Lakes Dredge & Dock
GLDD
| $106K | ﹤0.01% |
+10,100
| New | +$93.9K |
|
8916
Cingulate
CING
$71.9M
| $106K | ﹤0.01% |
+21,031
| New | +$119K |
|
8917
Inovio Pharmaceuticals
INO
$69M
| $105K | ﹤0.01% |
18,192
-3,839
| -17% | -$31.7K |
|
8918
CALL
Invesco Mortgage Capital
IVR
$805M
| $104K | ﹤0.01% |
+11,100
| New | +$99.7K |
|
8919
Full House Resorts
FLL
$89M
| $104K | ﹤0.01% |
20,749
-25,325
| -55% | -$129K |
|
|
DHF
8920
BNY Mellon High Yield Strategies Fund
DHF
$172M
| $104K | ﹤0.01% |
38,519
+25,624
| +199% | +$64.6K |
|
8921
iSpecimen
ISPC
$3.19M
| $103K | ﹤0.01% |
547
+522
| +2,088% | +$113K |
|
8922
ETRACS 2x Monthly Pay Leveraged US Small Cap High Dividend ETN Series B
SMHB
$23.2M
| $103K | ﹤0.01% |
+16,014
| New | +$96.9K |
|
|
BRDG
8923
DELISTED
Bridge Investment Group
BRDG
| $102K | ﹤0.01% |
+10,327
| New | +$84.3K |
|
8924
Verrica Pharmaceuticals
VRCA
$87.3M
| $101K | ﹤0.01% |
6,987
+3,603
| +106% | +$162K |
|
|
DGXX
8925
Digi Power X Inc
DGXX
$385M
| $101K | ﹤0.01% |
87,211
+45,388
| +109% | +$56.9K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.